Global Shortage of Cholera Vaccine Raises Public Health Concerns
Cholera, a deadly waterborne disease, is making a worrying comeback globally due to a critical shortage of the oral cholera vaccine. With a key manufacturer ceasing production, efforts to establish new facilities are underway. The resurgence of cholera highlights the lack of political will and financial investment in combating the disease, especially in regions with poor water and sanitation infrastructure. Urgent action is needed to prevent further loss of life.
WHO Approves New Oral Cholera Vaccine to Combat Global Outbreaks
Zambia battles a cholera outbreak with the approval of a new oral cholera vaccine, Euvichol-S, by the WHO. The increased production of the vaccine aims to address the global cholera crisis, with an expected rise in supply for 2024. Gavi and UNICEF are actively involved in response efforts, emphasizing preventive measures and control strategies to combat the escalating outbreaks.
Global Deployment of Rapid Diagnostic Tests to Boost Fight Against Cholera
The global deployment of over 1.2 million cholera rapid diagnostic tests to 14 countries is a significant step in the fight against cholera. This initiative aims to enhance outbreak detection, improve vaccination campaigns, and support national cholera control and elimination targets. The program, funded and coordinated by Gavi, the Vaccine Alliance, with procurement and delivery led by UNICEF, is a collaborative effort involving several partners. The long-term sustainability of the program depends on successful fundraising for Gavi’s next strategic period, spanning from 2026 to 2030.
Global Cholera Outbreak Causes Concern
A multi-country outbreak of cholera has caused concern worldwide, with over 787,000 reported cases and 5,500 deaths in 31 countries. The shortage of Oral Cholera Vaccines (OCV) has been a major challenge, with demand doubling the available supply. The World Health Organization (WHO) has classified the global resurgence of cholera as a grade 3 emergency, with the risk assessed as very high. For the latest data on the outbreak, the WHO Global Cholera and AWD Dashboard is available for reference.